Repurposing biguanides to target energy metabolism for cancer treatment

Nature Medicine

Volumn 20, Issue 6, 2014, Pages 591-593

  Pollak, Michael ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; METFORMIN; GUANIDINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; CANCER THERAPY; CELL TRANSFORMATION; CYTOSTASIS; DRUG MECHANISM; ENERGY METABOLISM; HUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; CLINICAL TRIAL (TOPIC); DRUG EFFECT; DRUG REPOSITIONING; METHODOLOGY; NEOPLASM;

CLINICAL TRIALS AS TOPIC; DRUG REPOSITIONING; ENERGY METABOLISM; GUANIDINES; HUMANS; METFORMIN; NEOPLASMS;

EID: 84902110574     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3596     Document Type: Short Survey

References (16)

1. Owen, M.R., Doran, E. & Halestrap, A.P. Biochem. J. 348, 607-614 (2000).
2. Shaw, R.J. et al. Science 310, 1642-1646 (2005).
3. Foretz, M. et al. J. Clin. Invest. 120, 2355-2369 (2010).
4. Franciosi, M. et al. PLoS ONE 8, e71583 (2013).
5. Suissa, S. & Azoulay, L. Diabetes Care 35, 2665-2673 (2012).
6. Pollak, M. Nat. Rev. Cancer 12, 159-169 (2012).
7. Pollak, M. J. Clin. Invest. 123, 3693-3700 (2013).
8. Wallace, D.C. Nat. Rev. Cancer 12, 685-698 (2012).
9. Zakikhani, M., Dowling, R., Fantus, I.G., Sonenberg, N. & Pollak, M. Cancer Res. 66, 10269-10273 (2006).
10. Larsson, O. et al. Proc. Natl. Acad. Sci. USA 109, 8977- 8982 (2012).
11. Algire, C. et al. Oncogene 30, 1174-1182 (2011).
12. Shackelford, D.B. et al. Cancer Cell 23, 143-158 (2013).
13. Birsoy, K. et al. Nature 508, 108-112 (2014).
14. Pollak, M. Cancer Cell 23, 263-264 (2013).
15. Gontier, E. et al. Eur. J. Nucl. Med. Mol. Imaging 35, 95-99 (2008).
16. Madiraju, A.K. et al. Nature published online, doi:10.1038/nature13270 (21 May 2014).